ES2045156T3 - Derivados de aminoacidos como anti-hipertensores. - Google Patents

Derivados de aminoacidos como anti-hipertensores.

Info

Publication number
ES2045156T3
ES2045156T3 ES88400373T ES88400373T ES2045156T3 ES 2045156 T3 ES2045156 T3 ES 2045156T3 ES 88400373 T ES88400373 T ES 88400373T ES 88400373 T ES88400373 T ES 88400373T ES 2045156 T3 ES2045156 T3 ES 2045156T3
Authority
ES
Spain
Prior art keywords
amino acid
acid derivatives
hypertensors
inhibitors
useful
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES88400373T
Other languages
English (en)
Inventor
Shizuo Saito
Motoshi Watanabe
Toshiaki Waga
Shinichi Matsui
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Asahi Breweries Ltd
Original Assignee
Asahi Breweries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Asahi Breweries Ltd filed Critical Asahi Breweries Ltd
Application granted granted Critical
Publication of ES2045156T3 publication Critical patent/ES2045156T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/022—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -X-C(=O)-(C)n-N-C-C(=O)-Y-; X and Y being heteroatoms; n being 1 or 2
    • C07K5/0222—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -X-C(=O)-(C)n-N-C-C(=O)-Y-; X and Y being heteroatoms; n being 1 or 2 with the first amino acid being heterocyclic, e.g. Pro, Trp
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06008—Dipeptides with the first amino acid being neutral
    • C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
    • C07K5/06026—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atom, i.e. Gly or Ala
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06086—Dipeptides with the first amino acid being basic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pyrrole Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

ESTA INVENCION SE REFIERE A DERIVADOS DE AMINOACIDOS, QUE SON UTILES COMO INHIBIDORES DEL ENZIMA CONVERTIDOR DE ANGIOTENSINA.
ES88400373T 1987-02-19 1988-02-18 Derivados de aminoacidos como anti-hipertensores. Expired - Lifetime ES2045156T3 (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP3444087 1987-02-19
JP8388587 1987-04-07
JP18065487 1987-07-17

Publications (1)

Publication Number Publication Date
ES2045156T3 true ES2045156T3 (es) 1994-01-16

Family

ID=27288419

Family Applications (1)

Application Number Title Priority Date Filing Date
ES88400373T Expired - Lifetime ES2045156T3 (es) 1987-02-19 1988-02-18 Derivados de aminoacidos como anti-hipertensores.

Country Status (5)

Country Link
US (1) US4897483A (es)
EP (1) EP0279750B1 (es)
CA (1) CA1313724C (es)
DE (1) DE3877591T2 (es)
ES (1) ES2045156T3 (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5721263A (en) * 1993-06-07 1998-02-24 Takeda Chemical Industries, Ltd. Pharmaceutical composition for angiotensin II-mediated diseases

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2208197A (en) * 1937-06-16 1940-07-16 John H Schreiber Joint breaker and cathead
IL58849A (en) * 1978-12-11 1983-03-31 Merck & Co Inc Carboxyalkyl dipeptides and derivatives thereof,their preparation and pharmaceutical compositions containing them
DE3177130D1 (de) * 1980-08-30 1990-01-11 Hoechst Ag Aminosaeurederivate, verfahren zu ihrer herstellung, diese enthaltende mittel und deren verwendung.
US4296110A (en) * 1980-10-28 1981-10-20 E. I. Du Pont De Nemours And Company Antihypertensive I-substituted cyclic lactam-2-carboxylic acids
DE3272505D1 (en) * 1981-03-09 1986-09-18 Merck & Co Inc Substituted thiazolidine carboxylic acid analogs and derivatives as antihypertensives
EP0065301A1 (en) * 1981-05-18 1982-11-24 Merck & Co. Inc. Isoquinoline carboxylic acid derivates, process for preparing and pharmaceutical composition containing the same
EP0079521A1 (en) * 1981-11-09 1983-05-25 Merck & Co. Inc. Process for preparation of carboxyalkyldipeptide derivatives
EP0080822A1 (en) * 1981-11-27 1983-06-08 Beecham Group Plc Anti-hypertensive prolinol-based peptides
AU569789B2 (en) * 1984-05-03 1988-02-18 Brigham And Women's Hospital A.c.e. inhibitors to treat renal diseases

Also Published As

Publication number Publication date
US4897483A (en) 1990-01-30
EP0279750A3 (en) 1990-04-25
DE3877591T2 (de) 1993-05-19
CA1313724C (en) 1993-02-16
EP0279750A2 (en) 1988-08-24
DE3877591D1 (en) 1993-03-04
EP0279750B1 (en) 1993-01-20

Similar Documents

Publication Publication Date Title
HN1999000131A (es) Derivados del acido hidroxi pipecolato hidroxamico.
HN1998000020A (es) Derivados de acido arilsulfonilhidroxamico.
SV1995000074A (es) Acidos 4-biarilbutirico o 5-biarilpentanoico sustituidos y sus derivados como inhibidores de las metaloproteasas de la matriz
MX9302876A (es) Inhibidores de doble accion.
ES2106965T3 (es) Nuevas 4-aza-5alfa-androstan-3-onas 7beta-sustituidas como inhibidores de 5alfa-reductasa.
DK572182A (da) Fremgangsmaade til fremstilling af phosphorholdige organiske forbindelser
ES2145267T3 (es) Nuevos derivados bisulfuro de mercaptoacetilamido de 1,3,4,5-tetrahidro-benzo(c)azepin-3-ona utiles como inhibidores de la encefalinasa y del enzima de conversion de la angiotensina.
CR6392A (es) Moduladores de ccr5
PT94568A (pt) Quinazolinonas substituidas como antagonistas da angiotensina ii
ATE435648T1 (de) Derivaten von nodulisporen säure
HN1997000146A (es) Derivados de pirimidina biciclica condensada
HN1999000221A (es) Moduladores de ccr5
ES2138622T3 (es) Derivados de mercaptoacetilamido piridazo(1,2-a)(1,2)diazepina utilizados como inhibidores de encefalinasa y eca.
ES2043626T3 (es) Procedimiento para obtener un preparado farmaceutico.
MX9306758A (es) Derivados novedosos mercaptoacetilamida de lactama biciclica, utiles como inhibidores de la encefalinasa y eca.
ES547931A0 (es) Procedimiento para la obtencion de un medicamento que con contiene como sustencia activa la combinacion de dihidropiridinas con inhibidores ace
ES2065881T3 (es) Nuevos inhibidores de dopamina beta-hidroxilasa.
ES2058176T3 (es) Un procedimiento para preparar un derivado peptidico.
ES2054732T3 (es) Un procedimiento para preparar un derivado peptidico.
MX9306666A (es) Nuevas azetidinonas substituidas como agentes antiinflamatorios y antidegenerativos.
ES2080732T3 (es) Derivados de hirudina con efecto retardado.
ES2139669T3 (es) Nuevos derivados triciclicos de indan-2-mercaptoacetilamida 2-substituidos utiles como inhibidores de la encefalinasa.
SE9604582D0 (sv) Novel compounds
ES2142490T3 (es) Ciclopeptolidos.
ES2052009T3 (es) Compuestos ciclicos que contienen azufre.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 279750

Country of ref document: ES